Elevated erythrocyte adenosine deaminase activity in Down's syndrome.

Area of Science:

• Biochemistry
• Genetics
• Clinical Medicine

Background:

• Down syndrome is associated with various biochemical alterations.
• Adenosine deaminase (ADA) plays a key role in purine metabolism.
• Understanding metabolic differences in Down syndrome is crucial for potential therapeutic targets.

Purpose of the Study:

• To investigate erythrocyte adenosine deaminase (ADA) activity in individuals with Down syndrome.
• To compare ADA activity between Down syndrome patients and age- and sex-matched controls.
• To explore potential implications for purine metabolism in Down syndrome.

Main Methods:

• Erythrocyte ADA activity was measured using spectrophotometric assays.
• Activity was quantified in 29 Down syndrome cases and 29 matched controls.
• Statistical analysis was performed to determine significance.

Main Results:

• Mean erythrocyte ADA activity was significantly higher in Down syndrome patients (1883 +/- 463 mU/g Hb) compared to controls (1361 +/- 294 mU/g Hb).
• The difference in ADA activity was statistically significant (p < 0.001).

Conclusions:

• Erythrocyte ADA activity is elevated in Down syndrome.
• This elevation suggests a potential disruption or alteration in purine metabolism pathways in Down syndrome.
• Further research into purine metabolism in Down syndrome is warranted.